Corporate Banner
Satellite Banner
Technology Networks Header
Sunday, January 25, 2015
 
Register | Sign in
Home Page>Products
  Product News
Revolutionize Routine Medical Testing with Latest ‘Super-Control’ from Randox
Wednesday, December 17, 2014
'Super Control' will revolutionize quality control in laboratories.

ONET Software Released
Wednesday, December 17, 2014
Bruker releases ONET Software for administration of FT-NIR spectrometer networks.

INTEGRA Focus on Liquid Handling at SLAS 2015
Tuesday, December 16, 2014
INTEGRA's VIAFLO 96 and VIAFLO 384 benchtop electronic pipettes will be on display.

Bio-Rad Introduces Bio-Plex Pro™ Human Inflammation Panels
Tuesday, December 16, 2014
Superior profiling of cancer, cardiovascular, and other disease biomarkers.

Bio-Rad Launches Easy-to-Use PureBlu™ Nuclear Staining Dyes
Tuesday, December 16, 2014
High purity, pre-aliquoted formulations for cell imaging experiments.

Low Profile 96-well Deep Well Plate
Monday, December 15, 2014
Porvair Sciences low profile 96-well deep well plate achieves a storage volume of 1.1ml / well in a height of just 27 mm enabling more plates to be stacked or stored in a given space.

SLAS2015 Liquid Handling Short Course
Saturday, December 13, 2014
SLAS partners with Artel to develop new “Liquid Handling Essentials” short course.

New Flexi-block Accessory from Techne
Saturday, December 13, 2014
Delivers new efficiency in sample heating.

Highly Efficient Neuro Transfection Reagent
Friday, December 12, 2014
DNA-In™ Neuro from AMSBIO offers a cost effective, robust and easy-to-use DNA delivery solution.

<< 3 4 5 6 7 8 9 >>
Showing Results 51 - 60 of 10830
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
SELECTBIO Market Reports
LabTube - Videos for the Scientific Community
eposters - The Online Journal of Scientific Posters
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn